SNOA — Sonoma Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $5.32m
- $0.12m
- $19.53m
Brief: Sonoma Pharmaceuticals Q1 Operating Expenses USD 2.6 Million
Sonoma Pharmaceuticals Q4 revenue rises 48% on US growth
Brief: Sonoma Pharmaceuticals Q4 Net Income USD -600 Thousand
Brief: Sonoma Pharmaceuticals Inc - Offers Units In Public Offering For Gross Proceeds Of $5 Million - SEC Filing
Sonoma Pharmaceuticals Q3 revenue rises 22%
Brief: Sonoma Pharmaceuticals Q3 Net Income USD -600 Thousand
Sonoma Pharmaceuticals Q2 revenue beats expectations on increased distributor sales
Brief: Sonoma Pharmaceuticals Inc - On Oct 18, Bruce Thornton Terminated As Executive Vice President And COO - SEC Filing
Brief: Sonoma Pharmaceuticals Inc - Enters At Market Issuance Sales Agreement With Ladenburg - SEC Filing
Sonoma Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Sonoma Pharmaceuticals' Q1 revenue rises 18%
Sonoma Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Sonoma Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary
Sonoma Pharmaceuticals Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Sonoma Pharmaceuticals Terminates Supply And Distribution Agreement With EMC Pharma
Sonoma Pharmaceuticals Inc expected to post a loss of 80 cents a share - Earnings Preview
Brief: Sonoma Pharmaceuticals Got Into Amendment No. 1 To Distribution Agreement With Medline Industries Dated Aug 19
Market An Expanded Eye Care Product Line
Brief: Sonoma Pharma Announces 1-For-20 Reverse Split Of Outstanding Common Stock